Checkpoint Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(9.8%)
Checkpoint Therapeutics | 4:持股變動聲明-股東 Fortress Biotech, Inc.
Checkpoint Therapeutics | EFFECT:其他
Checkpoint Therapeutics | UPLOAD:其他
Checkpoint Therapeutics | CORRESP:信函
Checkpoint Therapeutics | S-3:特定交易註冊聲明
Checkpoint Therapeutics | 10-Q:2024財年二季報
Checkpoint Therapeutics | 8-K:Checkpoint Therapeutics公佈2024年第二季度財務業績和最近的公司動態
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | D:發行公告
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | 424B5:募資說明書
Checkpoint Therapeutics | 4:持股變動聲明-高管 Oliviero James F III
Checkpoint Therapeutics | 4:持股變動聲明-高管 GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 8-K:重大事件
Checkpoint Therapeutics | 4:持股變動聲明-高管 GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 4:持股變動聲明-高管 Oliviero James F III
Checkpoint Therapeutics | S-8:員工福利計劃證券登記
Checkpoint Therapeutics | 3:首次持股聲明-股東 Fortress Biotech, Inc.
Checkpoint Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(11.2%)
暫無數據
暫無數據